DKSH

BRISTOL-MYERS SQUIBB PHARMA (THAILAND) LTD

Featured products of Bristol-Myers Squibb
entecavir
Packing/Price
30's
MIMS Class
Antivirals
ATC Classification
J05AF10 - entecavir : Belongs to the class of nucleoside and nucleotide reverse transcriptase inhibitors. Used in the systemic treatment of viral infections.
entecavir
Packing/Price
30's
MIMS Class
Antivirals
ATC Classification
J05AF10 - entecavir : Belongs to the class of nucleoside and nucleotide reverse transcriptase inhibitors. Used in the systemic treatment of viral infections.
hydroxyurea
Packing/Price
100's
MIMS Class
Cytotoxic Chemotherapy
ATC Classification
L01XX05 - hydroxycarbamide : Belongs to the class of other antineoplastic agents. Used in the treatment of cancer.
nivolumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy, Cancer Immunotherapy
ATC Classification
L01XC17 - nivolumab : Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.
nivolumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy, Cancer Immunotherapy
ATC Classification
L01XC17 - nivolumab : Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.
atazanavir sulfate
Packing/Price
60's
MIMS Class
Antivirals
ATC Classification
J05AE08 - atazanavir : Belongs to the class of protease inhibitors. Used in the systemic treatment of viral infections.
atazanavir sulfate
Packing/Price
30's
MIMS Class
Antivirals
ATC Classification
J05AE08 - atazanavir : Belongs to the class of protease inhibitors. Used in the systemic treatment of viral infections.
dasatinib
Packing/Price
60's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EA02 - dasatinib : Belongs to the class of BCR-ABL tyrosine kinase inhibitors. Used in the treatment of cancer.
dasatinib
Packing/Price
60's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EA02 - dasatinib : Belongs to the class of BCR-ABL tyrosine kinase inhibitors. Used in the treatment of cancer.
dasatinib
Packing/Price
60's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EA02 - dasatinib : Belongs to the class of BCR-ABL tyrosine kinase inhibitors. Used in the treatment of cancer.
ipilimumab
Packing/Price
1's
MIMS Class
Cancer Immunotherapy
ATC Classification
L01XC11 - ipilimumab : Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.
Distributed by DKSH
entecavir
Packing/Price
30's
MIMS Class
Antivirals
ATC Classification
J05AF10 - entecavir : Belongs to the class of nucleoside and nucleotide reverse transcriptase inhibitors. Used in the systemic treatment of viral infections.
entecavir
Packing/Price
30's
MIMS Class
Antivirals
ATC Classification
J05AF10 - entecavir : Belongs to the class of nucleoside and nucleotide reverse transcriptase inhibitors. Used in the systemic treatment of viral infections.
hydroxyurea
Packing/Price
100's
MIMS Class
Cytotoxic Chemotherapy
ATC Classification
L01XX05 - hydroxycarbamide : Belongs to the class of other antineoplastic agents. Used in the treatment of cancer.
nivolumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy, Cancer Immunotherapy
ATC Classification
L01XC17 - nivolumab : Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.
nivolumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy, Cancer Immunotherapy
ATC Classification
L01XC17 - nivolumab : Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.
atazanavir sulfate
Packing/Price
60's
MIMS Class
Antivirals
ATC Classification
J05AE08 - atazanavir : Belongs to the class of protease inhibitors. Used in the systemic treatment of viral infections.
atazanavir sulfate
Packing/Price
30's
MIMS Class
Antivirals
ATC Classification
J05AE08 - atazanavir : Belongs to the class of protease inhibitors. Used in the systemic treatment of viral infections.
dasatinib
Packing/Price
60's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EA02 - dasatinib : Belongs to the class of BCR-ABL tyrosine kinase inhibitors. Used in the treatment of cancer.
dasatinib
Packing/Price
60's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EA02 - dasatinib : Belongs to the class of BCR-ABL tyrosine kinase inhibitors. Used in the treatment of cancer.
dasatinib
Packing/Price
60's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EA02 - dasatinib : Belongs to the class of BCR-ABL tyrosine kinase inhibitors. Used in the treatment of cancer.
ipilimumab
Packing/Price
1's
MIMS Class
Cancer Immunotherapy
ATC Classification
L01XC11 - ipilimumab : Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.

Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in